Real-world study on efficacy and safety of pancreatin enteric-coated capsules in treatment of postprandial distress syndrome in older patients.

Changes in psychiatric symptoms During treatment, the average PHQ-9 scores of the three groups of patients showed a decreasing trend [ P < 0.05, Supplementary Table 3 , Figure 3a ], with the decrease maintained 2 weeks after the cessation of treatment [ Figure 3a ].

also in 42,184 other papers